Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
As of close of business last night, Ginkgo Bioworks Holdings Inc’s stock clocked out at $8.53, down -0.47%% from its previous closing price of $8.57. In other words, the price has decreased by -$0.47% from its previous closing price. On the day, 0.69 million shares were traded.
Ratios:
To gain a deeper understanding of DNA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.88 and its Current Ratio is at 4.88. In the meantime, Its Debt-to-Equity ratio is 0.67 whereas as Long-Term Debt/Eq ratio is at 0.67.
Raymond James Downgraded its Outperform to Mkt Perform on November 14, 2023, whereas the target price for the stock was revised from $3.50 to $2.50.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 23 ’25 when Che Austin bought 99 shares for $8.43 per share.
Che Austin bought 99 shares of DNA for $857 on Jun 20 ’25. On Jun 18 ’25, another insider, Che Austin, who serves as the Officer of the company, bought 99 shares for $8.46 each.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 2.10 while its Price-to-Book (P/B) ratio in mrq is 0.68.
Stock Price History:
Over the past 52 weeks, DNA has reached a high of $18.40, while it has fallen to a 52-week low of $5.00. The 50-Day Moving Average of the stock is 9.45%, while the 200-Day Moving Average is calculated to be -1.03%.
Shares Statistics:
A total of 43.08M shares are outstanding, with a floating share count of 38.14M. Insiders hold about 31.31% of the company’s shares, while institutions hold 57.97% stake in the company.
